Tuesday, 10 December 2019

Pharma News

  • TauRx gets $10.5 mn funding from Dundee Corp

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corporation. The investment will be used by TauRx primarily to support the...Read more

  • Zebrafish holds clue to drug-resistant epilepsy: NIH

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2013

    Singapore: According to a research by scientists at the University of California, San Francisco (UCSF), US, zebrafish carrying a specific mutation may help researchers discover treatments f...Read more

  • Irish firm's track-&-trace system to curb fake drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at eliminating the use of counterfeit drugs. Leading the battle against...Read more

  • FDA approves new labeling for Merck's HIV drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2013

    Singapore: Merck has received US FDA nod for new labeling for Isentress (raltegravir) film-coated tablets, Merck's integrase inhibitor for the treatment of HIV-1 infection in adult patients...Read more

  • Mylan launches generic version of Sporanox

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2012

    Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA) for Itraconazole Capsules, 100 mg. This product is the generic versi...Read more

  • F&S: Life Science companies can't afford to miss the next big thing

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: The top global pharmaceutical companies are employing new growth strategies to counter mounting industry challenges like patent expiration of several blockbuster drugs, as well ...Read more

  • Sosei initiates oropharyngeal candidiasis trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis. The study is an open-label, randomised, multiple centr...Read more

  • AstraZeneca boosts drug pipeline with $272 mn deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2012

    Singapore: AstraZeneca and Ardelyx entered into a worldwide exclusive licensing agreement for the latter's NHE3 inhibitor programme, including the phase II-ready lead compound RDX5791, for ...Read more

  • NIH to develop therapeutics for nicotine addiction

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: The National Institutes of Health (NIH), US, has launched three projects that will focus on development of therapeutics for fragile X syndrome, nicotine addiction, and age-relat...Read more

  • Boehringer shuts Petersburg plant, axes 240 staff

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: Boehringer Ingelheim Chemicals is going to close its Petersburg plant at the end of 2014. The facility will continue normal operations through the remainder of 2013 and phase out...Read more

  • Firm shuts after Alzheimer's trial fails in monkeys

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Singapore: US-based start-up Satori Pharmaceuticals shut down after running into safety problems in preclinical research of its lead program for Alzheimer's disease, according to FierceBiot...Read more

  • China to blacklist corrupt drugmakers

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2014

    Singapore: China has decided to introduce a healthcare corruption 'blacklist' this 2014 to nab drugmakers and medical device manufacturers found to have paid bribes. As part of its extende...Read more

  • Astellas, Cytokinetics sign $490 mn muscle deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&D and commercialization of skeletal muscle activators. The primary ...Read more

  • Astellas, XenoPort launch Regnite in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

    Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite is approved in Japan for the treatment of moderate-to-severe primary r...Read more

  • KHIDI, UAE armed forces sign healthcare MoA

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Korea Health Industry Development Institute (KHIDI) has signed a memorandum of agreement (MoA) for healthcare cooperation with the UAE Armed Forces on November 21, 2012. The MoA...Read more

  • Karnataka pharma policy: Introduce clusters to enhance sector

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

    Bangalore: The Indian state of Karnataka, which houses the most number of life science firms in the country, unveiled its new pharmaceutical policy. The new policy intends to introduce the ...Read more

  • NZ firm to raise funds for Australia trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 to finance a multi-center phase IIB trial of MIS416 in patients with s...Read more

  • Bangalore is synonymous with Biotech: BIB 2014

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Feb, 2014

    Bangalore: The pioneers from the Biotechnology industry gathered at the Bangalore India Bio 2014, as if with a renewed hope, to strike a chord with those who matter in the industry globally...Read more



Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls